Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant

INTRODUCTION: Disorders of glucose metabolism are a serious acromegaly comorbidity and may be differently impacted by medical treatments of acromegaly. In this retrospective longitudinal multicenter study, we investigated the outcome of glucose metabolism and its predictors in patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiloiro, Sabrina, Giampietro, Antonella, Visconti, Felicia, Rossi, Laura, Donfrancesco, Federico, Fleseriu, Cara M., Mirra, Federica, Pontecorvi, Alfredo, Giustina, Andrea, Fleseriu, Maria, De Marinis, Laura, Bianchi, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325668/
https://www.ncbi.nlm.nih.gov/pubmed/33907985
http://dx.doi.org/10.1007/s12020-021-02711-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325668/
https://www.ncbi.nlm.nih.gov/pubmed/33907985
http://dx.doi.org/10.1007/s12020-021-02711-3

Ejemplares similares